Indegene Ltd
Mon 2/02/2026,15:59:55 | NSE : INDGN
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 480.45
Previous Close
₹ 480.40
Volume
222869
Mkt Cap ( Rs. Cr)
₹11789.88
High
₹ 496.00
Low
₹ 477.50
52 Week High
₹ 640.10
52 Week Low
₹ 455.60
Book Value Per Share
₹ 119.28
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Indegene Ltd
Your Vote -
Buy
80.00%
Hold
0.00%
Sell
20.00%
80.00%
5 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
490.75
46
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
46
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Indegene Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Indegene - Copy of Newspaper Publication
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Indegene - General Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Indegene - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Indegene - Allotment of Securities
-
Indegene - Financial Results With Limited Review Report
-
Indegene Q3 net profit down 30.26% at Rs 34.80 cr
-
Indegene - Monitoring Agency Report
-
Indegene - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Press Release
-
Indegene - Board Meeting Outcome for Outcome Of Board Meeting
-
Indegene - Outcome of Board Meeting
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Press Release
-
Indegene - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Indegene - Shareholders meeting
-
Indegene - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Indegene - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Indegene - Change in Director(s)
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Board Meeting Intimation for The Consideration And Approval Of The Unaudited Consolidated And Standalone Financi
-
Indegene has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025
-
Indegene - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Indegene - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Indegene - Amalgamation/Merger
-
Indegene - Announcement under Regulation 30 (LODR)-Restructuring
-
Indegene - ESOP/ESOS/ESPS
-
Indegene - Acquisition
-
Indegene - Announcement under Regulation 30 (LODR)-Acquisition
-
Indegene - Trading Window
-
Indegene - Copy of Newspaper Publication
-
Indegene - Shareholders meeting
-
Indegene - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Indegene - ESOP/ESOS/ESPS
-
Indegene - Change in Director(s)
-
Indegene - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Indegene - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Acquisition
-
Indegene - Acquisition
-
Indegene - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene Ltd
-
Indegene Ltd
-
Indegene
-
Indegene
-
Indegene announces strategic collaboration with Microsoft
Key fundamentals
Evaluate the intrinsic value of Indegene Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 1888.2 | 953.8 | 795.3 | 650 | 442.2 |
| Liabilities | 1888.2 | 953.8 | 795.3 | 650 | 442.2 |
| Equity | 47.9 | 44.4 | 44.3 | 0.4 | 0.3 |
| Gross Profit | 180.5 | 168 | 177.9 | 168.7 | 150.4 |
| Net Profit | 181.3 | 137.9 | 130.2 | 132.7 | 133.4 |
| Cash From Operating Activities | 129 | 176.2 | 81.9 | 38.2 | 54.6 |
| NPM(%) | 16.57 | 13.18 | 12.94 | 15.85 | 26.1 |
| Revenue | 1093.6 | 1045.6 | 1005.7 | 836.7 | 511 |
| Expenses | 913.1 | 877.6 | 827.8 | 668 | 360.6 |
| ROE(%) | 6.32 | 4.81 | 4.54 | 4.63 | 4.65 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 13 Jun 2025 | 2 | 100 | 0 | 571.5 |
Peers
Other companies within the same industry or sector that are comparable to Indegene Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Visagar Polytex Ltd | 0.56 | 0.00 | 0.00 | 14111.11 | -5.68 | 0.00 |
| India Motor Parts and Accessories Ltd | 1067.40 | -0.21 | 15.31 | 601.66 | 670.43 | 2.81 |
| Madhya Pradesh Today Media Ltd | 47.55 | 0.00 | 6.23 | 220.22 | 69.80 | 0.00 |
| Hathway Cable and Datacom Ltd | 10.82 | -0.18 | 18.34 | 85336.52 | 26.13 | 0.00 |
Company Info
Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India.2025-Deloitte Names Indegene a Winner of Enterprise Growth Awards 2025.-"Indegene Wins BIG Innovation Award_January 2025."-Indegene Acquired BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma.-Everest Group Recognized Indegene as a Leader in Life Sciences AI and Analytics for Commercial PEAK Matrix Assessment 2025.-Indegene Launched NEXT Medical Writing Automation to Streamline Complex Medical Writing Workflows with GenAI.-Indegene Launched Cortex, A Fit-For-Purpose Generative AI Platform, Verticalized For The Life Sciences Industry.
Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India.2025-Deloitte Names Indegene a Winner of Enterprise Growth Awards 2025.-"Indegene Wins BIG Innovation Award_January 2025."-Indegene Acquired BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma.-Everest Group Recognized Indegene as a Leader in Life Sciences AI and Analytics for Commercial PEAK Matrix Assessment 2025.-Indegene Launched NEXT Medical Writing Automation to Streamline Complex Medical Writing Workflows with GenAI.-Indegene Launched Cortex, A Fit-For-Purpose Generative AI Platform, Verticalized For The Life Sciences Industry.
Read More
Parent Organisation
Indegene Ltd.
Founded
16/10/1998
Managing Director
Mr.Manish Gupta
NSE Symbol
INDGNEQ
FAQ
The current price of Indegene Ltd is ₹ 490.75.
The 52-week high for Indegene Ltd is ₹ 496.00 and the 52-week low is ₹ 477.50.
The market capitalization of Indegene Ltd is currently ₹ 11789.88. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Indegene Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Indegene Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Indegene Ltd shares.
The CEO of Indegene Ltd is Mr.Manish Gupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.